Meeting
2014 Genitourinary Cancers Symposium
Using ΝΒΝ to predict biochemical relapse following image-guided radiotherapy (IGRT) for intermediate-risk prostate cancer (IR-PCa).
Authors
Alejandro Berlin
Department of Radiation Oncology, Princess Margaret Cancer Centre/University Health Network, University of Toronto, Toronto, ON, Canada
Alejandro Berlin , Emilie Lalonde , Gaetano Zafarana , Jenna Sykes , Varune Rohan Ramnarine , Wan Lam , Alice Meng , Michael Milosevic , Theodorus van der Kwast , Paul C Boutros , Robert Glen Bristow
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Prostate Cancer
Track
Prostate Cancer
Sub Track
Prostate Cancer
Citation
J Clin Oncol 32, 2014 (suppl 4; abstr 26)
DOI
10.1200/jco.2014.32.4_suppl.26
Abstract #
26
Poster Bd #
B10
Abstract Disclosures
Similar Posters
Poster
2016 Genitourinary Cancers Symposium
Prognostic value of copy-number alterations of the Cohesin complex in intermediate-risk prostate cancer recurrence.
First Author: Jonathan So
Poster
2013 Genitourinary Cancers Symposium
Effect of germ-line BRCA mutations in biochemical relapse and survival after treatment for localized prostate cancer.
First Author: Elena Castro
Poster
2023 ASCO Annual Meeting
The spectrum of homologous recombination deficiency in cervical cancer: Is it also a cervical issue?
First Author: Muhammad Danyal Ahsan
Poster
2023 ASCO Annual Meeting
Effect of homologous recombination deficient (HRD) breast cancers on a distinct immune marker phenotype by comprehensive genomic and immune profiling (CGIP).
First Author: Heidi Chwan Ko